Validity of the shuttle walk test as a functional assessment of walking ability in individuals with polyneuropathy

References

• Lindeman E, Leffers P, Spaans F, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995;76:612–620.
   PubMed Web of Science ®Google Scholar
• Erdmann PG, van Meeteren NLU, Kalmijn S, et al. Functional health status of patients with chronic inflammatory neuropathies. J Peripher Nerv Syst. 2005;10:181–189.
   PubMed Web of Science ®Google Scholar
• Graham RC, Hughes RA. Clinimetric properties of a walking scale in peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2006;77:977–979.
   PubMed Web of Science ®Google Scholar
• Schröder C, Johnston M, Teunissen L, et al. Perceived control is a concurrent predictor of activity limitations in patients with chronic idiopathic axonal polyneuropathy. Arch Phys Med Rehabil. 2007;88:63–69.
   PubMed Web of Science ®Google Scholar
• Wade DT. Measurements in neurological rehabilitation. Oxford: Oxford University Press; 1992.
   Google Scholar
• Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil. 2001;82:9–13.
   PubMed Web of Science ®Google Scholar
• Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195–201.
   PubMed Web of Science ®Google Scholar
• Comi G, Roveri L, Swan A, et al. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol. 2002;249:1370–1377.
   PubMed Web of Science ®Google Scholar
• Merkies IS, Schmitz PI, Van Der Meché FG, et al. Comparison between impairment and disability scales in immune-mediated polyneuropathies. Muscle Nerve. 2003;28:93–100.
   PubMed Web of Science ®Google Scholar
• Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain. 2004;127:1723–1730.
   PubMed Web of Science ®Google Scholar
• Reilly MM, de Jonghe P, Pareyson D. 136th ENMC international workshop: Charcot-Marie-tooth disease type 1A (CMT1A) 8-10 April 2005, Naarden, the Netherlands. Neuromuscul Disord. 2006;16:396–402.
   PubMedGoogle Scholar
• Solari A, Laurà M, Salsano E, et al. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord. 2008;18:19–26.
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Rakocevic G, Salajegheh M, et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol. 2009;65:286–293.
   PubMed Web of Science ®Google Scholar
• Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing. 1997;26:15–19.
   PubMed Web of Science ®Google Scholar
• Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: six-minute walk test, Berg balance scale, timed up & go test, and gait speeds. Phys Ther. 2002;82:128–137.
   PubMed Web of Science ®Google Scholar
• Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47:1019–1024.
   PubMed Web of Science ®Google Scholar
• Solway S, Brooks D, Lacasse Y, et al. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119:256–270.
   PubMed Web of Science ®Google Scholar
• Parreira VF, Janaudis-Ferreira T, Evans RA, et al. Measurement properties of the incremental shuttle walk test, a systematic review. Chest. 2014;145:1357–1369.
   PubMed Web of Science ®Google Scholar
• Probst VS, Hernandes NA, Teixeira DC, et al. Reference values for the incremental shuttle walking test. Respir Med. 2012;106:243–248.
   PubMed Web of Science ®Google Scholar
• Harrison SL, Greening NJ, Houchen-Wolloff L, et al. Age-specific normal values for the incremental shuttle walk test in a healthy British population. J Cardiopulm Rehabil Prev. 2013;33:309–313.
   PubMed Web of Science ®Google Scholar
• Erdmann PG, Teunissen LL, van Genderen FR, et al. Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol. 2007;254:1204–1211.
   PubMed Web of Science ®Google Scholar
• Erdmann PG, Lindeman E, Cats EA, et al. Functioning of patients with multifocal motor neuropathy. J Peripher Nerv Syst. 2010;15:113–119.
   PubMed Web of Science ®Google Scholar
• Notermans NC, Wokke JHJ, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry. 1993;56:1066–1071.
   PubMed Web of Science ®Google Scholar
• van Asseldonk JT, Franssen H, van den Berg-Vos RM, et al. Multifocal motor neuropathy. Lancet Neurol. 2005;4:309–319.
   PubMed Web of Science ®Google Scholar
• van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–607.
   PubMed Web of Science ®Google Scholar
• Hulzebos EHJ, van Elk N, Sabelis LWE, et al. De validiteit van de gemodificeerde shuttle Wandel test bij patiënten met chronisch hartfalen. Ned Tijdschr Fysiother. 2006;116:16–20.
   Google Scholar
• Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
   PubMed Web of Science ®Google Scholar
• Pestman WR. Mathematical Statistics: an introduction. Berlin: Walter de Gruyter Verlag; 1998.
   Google Scholar
• Brach JS, VanSwearingen JM, Newman AB, et al. Identifying early decline of physical function in community-dwelling older women: performance-based and self-report measures. Phys Ther. 2002;82:320–328.
   PubMed Web of Science ®Google Scholar
• Novak P, Burger H, Marincek C, et al. Influence of foot pain on walking ability of diabetic patients. J Rehabil Med. 2004;36:249–252.
   PubMed Web of Science ®Google Scholar
• Mathur S, Reid WD, Levy RD. Exercise limitation in recipients of lung transplants. Phys Ther. 2004;84:1178–1187.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37:153–156.
   PubMed Web of Science ®Google Scholar
• Stratford PW, Binkley FM, Riddle DL. Health status measures: strategies and analytic methods for assessing change scores. Phys Ther. 1996;76:1109–1123.
   PubMed Web of Science ®Google Scholar
• Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ. 2005;330:644–648.
   PubMed Web of Science ®Google Scholar
• van Nes SI, Faber CG, Merkies IS. Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials. J Peripher Nerv Syst. 2008;13:136–147.
   PubMed Web of Science ®Google Scholar